XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net loss $ (1,028,857) $ (204,149) $ (623,506)
Net loss before tax (1,036,161) (201,746) (632,570)
Loss from operations (1,048,703) (215,012) (593,511)
Gross profit 1,918,717 1,762,202 1,422,918
Revenue 2,758,867 2,499,766 2,084,279
Cost of sales 840,150 737,564 661,361
Total operating expenses 2,976,620 2,055,641 2,003,185
Research and development 431,210 426,927 394,191
Sales and marketing 894,125 827,805 929,644
General and administrative 781,825 800,288 663,381
Impairment of long-lived and indefinite-lived assets 869,460 621 15,969
Other operating income (loss) 9,200 78,427 (13,244)
Total other income (expense) 12,542 13,266 (39,059)
Investment income (loss), net 39,558 32,713 (19,425)
Interest Expense, Nonoperating (27,016) (19,447) (19,634)
Income Tax Expense (Benefit) $ 7,304 $ (2,403) $ 9,064
Increase (decrease) in net loss per share (in usd per share) $ (5.59) $ (1.13) $ (3.54)
Increase (decrease) in net loss per share (in usd per share) $ (5.59) $ (1.13) $ (3.54)
Weighted average number of shares outstanding, basic (in shares) 184,197 180,144 176,351
Weighted average number of shares outstanding, diluted (in shares) 184,197 180,144 176,351